Overview
Quilt Health runs a data- and technology-driven engagement platform that connects provider networks, patient populations, and R&D entities to improve access to treatments for rare diseases. The platform supports clinical trial recruitment and faster patient access to approved therapies, while providing data insights to R&D partners to speed development and commercialization. It differentiates itself by focusing on the rare-disease space, uniting clinicians, patients, and researchers to reduce enrollment challenges and fragmentation. Its goal is to increase access to therapies for millions affected by rare diseases and accelerate the development and delivery of orphan drugs.
Work here?Claim your company
Simplify's take
What believers are saying
- Quilt Health raised $6 million in June 2025 from MaC and Underscore Ventures.
- Its site updated October 4, 2026, signaling active product and partnership momentum.
- The NASCC alliance gives immediate access to 115 centers and underserved patient populations.
What critics are saying
- Quilt Health remains a young 2024 startup with $8 million total funding and thin runway.
- A narrow sickle cell focus creates existential dependence on NASCC adoption and one disease niche.
- Clinical-trial intermediaries face brutal proof risk if sponsors demand randomized enrollment gains by 2027.
What makes Quilt Health unique
- Quilt Health paired software with NASCC's 115-center sickle cell network in March 2025.
- It connects clinics, community, and home through one workflow for complex-condition care.
- Founder Andy Ellner targets sickle cell first, then hematologic, neurological, and cardiovascular disorders.
Help us improve and share your feedback! Did you find this helpful?
Funding
Industry standards